Abstract:The KCNJ11 gene encodes the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium (KATP ) channel, which plays a key role in insulin secretion. Monogenic diseases caused by KCNJ11 gene mutation are rare and easily misdiagnosed. It has been shown that mutations in the KCNJ11 gene are associated with neonatal diabetes mellitus (NDM), maturity-onset diabetes of the young 13 (MODY13), type 2 diabetes mellitus (T2DM), and hyperinsulinemic hypoglycemia. We report four patients with KCNJ11 gene mutations and provide a systematic review of the literature. A boy with diabetes onset at the age of 1 month was misdiagnosed as type 1 diabetes mellitus (T1DM) for 12 years and received insulin therapy continuously, resulting in poor glycemic control. He was diagnosed as NDM with KCNJ11 E322K gene mutation, and glibenclamide was given to replace exogenous insulin. The successful transfer time was 4 months, much longer than the previous unsuccessful standard of 4 weeks. The other three patients were two sisters and their mother; the younger sister was misdiagnosed with T1DM at 13 years old, while the elder sister was diagnosed with diabetes (type undefined) at 16 years old. They were treated with insulin for 3 years, with poor glycemic control. Their mother was diagnosed with T2DM and achieved good glycemia control with glimepiride. They were diagnosed as MODY13 because of the autosomal dominant inheritance of two generations, early onset of diabetes before 25 years of age in the two sisters, and the presence of the KCNJ11 N48D gene mutation. All patients successfully transferred to sulfonylureas with excellent glycemic control. Therefore, the wide spectrum of clinical phenotypes of glucose dysmetabolism caused by KCNJ11 should be recognized to reduce misdiagnosis and implement appropriate treatment.

A Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cells

Kir 6.2 activating mutation and neonatal diabetes

Gain of Function Mutation in K(ATP) Channels and Resulting Upregulation of Coupling Conductance are Partners in Crime in the Impairment of Ca 2+ Oscillations in Pancreatic ß-cells

A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life

Implication of Oxygen-Regulated Protein 150 (ORP150) in Apoptosis Induced by Proteasome Inhibitors in Human Thyroid Cancer Cells

Expression of Insulin and ATP-sensitive Potassium (KATP) Channels in Pancreas of Neonatal Rats with Low Birth Weight

From Hyper- to Hypoinsulinemia and Diabetes: Effect of KCNH6 on Insulin Secretion.

Structure of an open KATP channel reveals tandem PIP2 binding sites mediating the Kir6.2 and SUR1 regulatory interface

Structure of an open K channel reveals tandem PIP binding sites mediating the Kir6.2 and SUR1 regulatory interface

Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes

The Effects of E23K Polymorphism in Kir6.2 Subunit on Insulin Sensitivity in Skeletal Muscle Cells by Long-Chain Fatty Acyl CoA.

Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature

Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity

KATP channel mutation disrupts hippocampal network activity and nocturnal gamma shifts

Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes

Single Nucleotide Polymorphisms In K-Atp Channels - Muscular Impact On Type 2 Diabetes

22 Pharmacogenetics for T 2 DM and Anti-Diabetic Drugs

Single Nucleotide Polymorphisms in KATP Channels

Pharmacogenetics for T2DM and Anti-Diabetic Drugs

Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes

Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes